These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 26858381)

  • 21. Progress toward polio eradication--Worldwide, 2013-2014.
    Moturi EK; Porter KA; Wassilak SG; Tangermann RH; Diop OM; Burns CC; Jafari H;
    MMWR Morb Mortal Wkly Rep; 2014 May; 63(21):468-72. PubMed ID: 24871252
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polio Eradication and Endgame Plan - Victory within Grasp.
    Patel M; Menning L; Bhatnagar P
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S28-S32. PubMed ID: 27771636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. COVID-19 in Pakistan: Impact on global polio eradication initiative.
    Haqqi A; Zahoor S; Aftab MN; Tipu I; Rehman Y; Ahmed H; Afzal MS
    J Med Virol; 2021 Jan; 93(1):141-143. PubMed ID: 32603503
    [No Abstract]   [Full Text] [Related]  

  • 24. Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan.
    van den Ent MMVX; Swift RD; Anaokar S; Hegg LA; Eggers R; Cochi SL
    J Infect Dis; 2017 Jul; 216(suppl_1):S244-S249. PubMed ID: 28838165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multi-pronged scoping review approach to understanding the evolving implementation of the Smallpox and Polio eradication programs: what can other Global Health initiatives learn?
    Schleiff M; Olateju A; Decker E; Neel AH; Oke R; Peters MA; Rao A; Alonge O
    BMC Public Health; 2020 Dec; 20(Suppl 4):1698. PubMed ID: 33339517
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polio Eradication Initiative: Contribution to improved communicable diseases surveillance in WHO African region.
    Mwengee W; Okeibunor J; Poy A; Shaba K; Mbulu Kinuani L; Minkoulou E; Yahaya A; Gaturuku P; Landoh DE; Nsubuga P; Salla M; Mihigo R; Mkanda P
    Vaccine; 2016 Oct; 34(43):5170-5174. PubMed ID: 27389170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Introduction of Inactivated Polio Vaccine, Withdrawal of Type 2 Oral Polio Vaccine, and Routine Immunization Strengthening in the Eastern Mediterranean Region.
    Fahmy K; Hampton LM; Langar H; Patel M; Mir T; Soloman C; Hasman A; Yusuf N; Teleb N
    J Infect Dis; 2017 Jul; 216(suppl_1):S86-S93. PubMed ID: 28838199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Addressing the Challenges and Opportunities of the Polio Endgame: Lessons for the Future.
    Patel M; Cochi S
    J Infect Dis; 2017 Jul; 216(suppl_1):S1-S8. PubMed ID: 28838196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global Polio Eradication,The Journey So Far.
    Thacker N; Yewale VN; Pathak A
    Indian Pediatr; 2016 Aug; 53 Suppl 1():S61-S64. PubMed ID: 27771642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sampling method for surveying complex and multi-institutional partnerships: lessons from the Global Polio Eradication Initiative.
    Peters MA; Deressa W; Sarker M; Sharma N; Owoaje E; Ahmad RA; Saljuqi T; Mafuta E; Alonge O
    BMC Public Health; 2020 Aug; 20(Suppl 2):1197. PubMed ID: 32787958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Using the Stop Transmission of Polio (STOP) Program to Develop a South Sudan Expanded Program on Immunization Workforce.
    Tchoualeu DD; Hercules MA; Mbabazi WB; Kirbak AL; Usman A; Bizuneh K; Sandhu HS
    J Infect Dis; 2017 Jul; 216(suppl_1):S362-S367. PubMed ID: 28838163
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress toward poliomyelitis eradication--Afghanistan and Pakistan, January 2013-August 2014.
    Farag NH; Alexander J; Hadler S; Quddus A; Durry E; Wadood MZ; Tangermann RH; Ehrhardt D;
    MMWR Morb Mortal Wkly Rep; 2014 Oct; 63(43):973-7. PubMed ID: 25356605
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and translation of research and innovations from polio eradication (STRIPE): initial findings from a global mixed methods study.
    Alonge O; Neel AH; Kalbarczyk A; Peters MA; Mahendradhata Y; Sarker M; Owoaje E; Deressa W; Kayembe P; Salehi AS; Gupta SD
    BMC Public Health; 2020 Aug; 20(Suppl 2):1176. PubMed ID: 32787949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lessons learned from the Global Polio Eradication Initiative: A roadmap for the international COVID-19 vaccination campaign.
    Belshe WB; Alswang JM; Uplift-Brown AM; Chilenga L; Chipolombwe J; Seaman VY
    Malawi Med J; 2022 Dec; 34(4):294-298. PubMed ID: 38125783
    [TBL] [Abstract][Full Text] [Related]  

  • 35. National, Regional and Global Certification Bodies for Polio Eradication: A Framework for Verifying Measles Elimination.
    Deblina Datta S; Tangermann RH; Reef S; William Schluter W; Adams A
    J Infect Dis; 2017 Jul; 216(suppl_1):S351-S354. PubMed ID: 28838172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CORE Group Polio Project: An Overview of Its History and Its Contributions to the Global Polio Eradication Initiative.
    Losey L; Ogden E; Bisrat F; Solomon R; Newberry D; Coates E; Ward D; Hilmi L; LeBan K; Burrowes V; Perry HB
    Am J Trop Med Hyg; 2019 Oct; 101(4_Suppl):4-14. PubMed ID: 31760971
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-polio vaccinations in the third millennia.
    Icardi G; Tassinari F
    Ann Ig; 2018; 30(4 Supple 1):11-15. PubMed ID: 30062374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of the Stop Transmission of Polio (STOP) program in developing countries: the experience of Kenya.
    Tesfaye B; K Makam J; Sergon K; Onuekwusi I; Muitherero C; Sowe A
    BMC Public Health; 2020 Jul; 20(1):1110. PubMed ID: 32664859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coordination as a best practice from the polio eradication initiative: Experiences from five member states in the African region of the World Health Organization.
    Okeibunor J; Nsubuga P; Salla M; Mihigo R; Mkanda P
    Vaccine; 2016 Oct; 34(43):5203-5207. PubMed ID: 27381643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nigeria experience on the use of polio assets for the 2017/18 measles vaccination campaign follow-up.
    Oteri AJ; Adamu U; Dieng B; Bawa S; Terna N; Nsubuga P; Owoaje ET; Kassogue M; Jean Baptiste AE; Braka F; Shuaib F
    Vaccine; 2021 Nov; 39 Suppl 3():C3-C11. PubMed ID: 33962837
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.